Mortality trends in chronic liver disease and cirrhosis from 1981 to 2015 in Taiwan.

Shih-Yung SuLong-Teng LeeWen-Chung Lee

Published in: Population health metrics (2021)

The National Viral Hepatitis Therapy Program in Taiwan may have contributed to the decrease in mortality rates for chronic liver disease and cirrhosis in adulthood.

Keyphrases

quality improvement
cardiovascular events
risk factors
sars cov
depressive symptoms
mesenchymal stem cells
cell therapy
replacement therapy